Chronic Urticaria

Older patients with chronic urticaria have characteristics that are unique compared with younger patients, such as high rates of autoimmunity and malignancy, according to a study.

The Pfizer-BioNTech BNT162b2 COVID-19 vaccine was not associated with any risk for adverse reactions among children with chronic urticaria, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Alpha-gal sensitization did not appear prevalent among patients with chronic urticaria, with few patients experiencing clinically relevant alpha-gal allergy, according to a letter published in Clinical and Translational Allergy.

CLEVELAND — Options lessen for patients with chronic urticaria who do not respond to initial antihistamine treatment, according to James Fernandez, MD, PhD, of the department of allergy and immunology at the Cleveland Clinic.

Interested in allergy-specific content from the American Academy of Dermatology Annual Meeting but could not attend in person? Healio presents this list of meeting coverage that might be relevant to your allergy/immunology practice.

Lirentelimab improved disease control among patients with antihistamine-refractory chronic urticaria, according to results of an open-label, proof-of-concept study published in The Journal of Allergy and Clinical Immunology.

Patients with chronic urticaria appeared at an increased risk for obstructive sleep apnea, with higher disease activity correlating with greater risk, according to a study published in World Allergy Organization Journal.